medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/ms2024-202medsovet-8268Research ArticleСАХАРНЫЙ ДИАБЕТDIABETES MELLITUSПриоритеты самоконтроля гликемии – важная составляющая успеха терапии сахарного диабетаPriorities of self-monitoring of glycemia: an important component of successful diabetes managementhttps://orcid.org/0000-0001-9007-4123БирюковаЕ. В.BiryukovaE. V.

Бирюкова Елена Валерьевна, д.м.н., профессор кафедры эндокринологии и диабетологии

127473, Москва, ул. Делегатская, д. 20, стр. 1

Elena V. Biryukova, Dr. Sci. (Med.), Professor of the Department of Endocrinology and Diabetology

20, Bldg. 1, Delegatskaya St., Moscow, 127473

lena@obsudim.ruhttps://orcid.org/0000-0003-1548-1487ШинкинМ. В.ShinkinМ. V.

Шинкин Михаил Викторович, научный сотрудник отдела эндокринных и метаболических нарушений, врач-эндокринолог

111123, Москва, Новогиреевская ул., д. 1

Mikhail V. Shinkin, Research Associate of the Department of Endocrine and Metabolic Disorders, Endocrinologist

1, Novogireevskaya St., Moscow, 111123

m.shinkin@mknc.ruРоссийский университет медицины (РосУниМед)РоссияRussian University of Medicine (ROSUNIMED)Russian FederationМосковский клинический научный центр имени А.С. ЛогиноваРоссияLoginov Moscow Clinical Scientific CenterRussian Federation202418052024063643Copyright © Бирюкова Е.В., Шинкин М.В., 20242024Бирюкова Е.В., Шинкин М.В.Biryukova E.V., Shinkin М.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/8268

Эффективное лечение сахарного диабета (СД) – важная задача современной медицины. Хроническая гипергликемия – ключевой фактор в патогенезе хронических диабетических осложнений, определяющих прогноз жизни. Достижение и поддержание оптимального гликемического контроля имеет первостепенное значение для лечения СД и снижения риска всего спектра диабетических осложнений. Обсуждается роль самоконтроля гликемии (СКГ) в управлении СД и в профилактике развития диабетических осложнений. Стабильная компенсация СД может быть достигнута при использовании эффективной терапии и регулярного СКГ, несущего точную и оперативную информацию о состоянии углеводного обмена. Лечение СД как хронического заболевания представляет пожизненный процесс, в котором, несомненно, должен участвовать и врач, и пациент. СКГ вовлекает пациентов в лечебный процесс, наделяет их возможностью стать его активным полноценным участником, помогает улучшить гликемический контроль. Отсутствие должного контроля гликемии является одной из причин неудовлетворительных показателей гликемии у многих пациентов с СД. Представлены данные клинических исследований и реальной клинической практики, демонстрирующие улучшение показателей углеводного обмена при регулярном СКГ. Уровень HbA1c начинает значимо улучшаться, как только пациент увеличивает частоту СКГ независимо от типа СД или вида сахароснижающей терапии. Современное понимание СКГ подразумевает определенную кратность систематических измерений уровней глюкозы. Передовые технологии дают дополнительные возможности для достижения оптимального и безопасного уровня глюкозы в крови у пациентов с СД с помощью современных глюкометров. Соответствие стандартам точности является наиболее важным критерием для выбора глюкометра при удобстве и простоте его в использовании.

Effective treatment of diabetes mellitus (DM) is modern medicine’s big challenge. Chronic hyperglycemia is a key factor in the pathogenesis of chronic diabetic complications that determine life prognosis. Achieving and maintaining optimal glycemic controli is crucial for the management of diabetes and minimizing the risk of the whole range of diabetic complications. The role of self-monitoring of glycemia (SMG) in the management of diabetes and in the prevention of diabetic complications is discussed. Stable compensation of DM can be achieved by using effective therapy and regular SMG, which provides accurate and timely information about carbohydrate metabolism status. Treatment of diabetes as a chronic disease is a lifelong processs, in which both the doctor and the patient must definitely participate. SMG involves patients in the treatment process, provides them with the opportunity to become its active full-fledged participant, and helps improve glycemic control. Lack of proper glycemic control is one of the reasons for unsatisfactory glycemic levels in many patients with diabetes. Findings from clinical studies and real-world clinical practice demonstrating an improvement in carbohydrate metabolism markers due to regular SMG are presented. HbA1c levels begin to improve significantly as soon as the patient improves the frequency of SCG, regardless of the type of DM or the type of glucose-lowering therapy. The modern understanding of SMG implies a certain frequency of routine measurements of glucose levels. Advanced technologies provide additional opportunities to achieve optimal and safe blood glucose levels in patients with DM using modern blood glucose meters. Compliance with standards of accuracy is the most important criterion for choosing a blood glucose meter that is convenient and easy to use.

сахарный диабет 2-го типагипергликемиягликированный гемоглобингипогликемииглюкометрыdiabetes mellitus type 2hyperglycemiaglycated hemoglobinhypoglycemiablood glucose metersReferencesKhan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107–111. https://doi.org/10.2991/jegh.k.191028.001.Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107–111. https://doi.org/10.2991/jegh.k.191028.001.Liu J, Ren ZH, Qiang H, Wu J, Shen M, Zhang L, Lyu J. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health. 2020;20(1):1415. https://doi.org/10.1186/s12889-020-09502-x.Liu J, Ren ZH, Qiang H, Wu J, Shen M, Zhang L, Lyu J. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health. 2020;20(1):1415. https://doi.org/10.1186/s12889-020-09502-x.Wu H, Patterson CC, Zhang X, Ghani RBA, Magliano DJ, Boyko EJ et al. Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Res Clin Pract. 2022;185:109785. https://doi.org/10.1016/j.diabres.2022.109785.Wu H, Patterson CC, Zhang X, Ghani RBA, Magliano DJ, Boyko EJ et al. Worldwide estimates of incidence of type 2 diabetes in children and adolescents in 2021. Diabetes Res Clin Pract. 2022;185:109785. https://doi.org/10.1016/j.diabres.2022.109785.Dabelea D, Rewers A, Stafford JM, Standiford DA, Lawrence JM, Saydah S et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938–45. https://doi.org/10.1542/peds.2013-2795.Dabelea D, Rewers A, Stafford JM, Standiford DA, Lawrence JM, Saydah S et al. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938–45. https://doi.org/10.1542/peds.2013-2795.Черников АА, Северина АС, Шамхалова МШ, Шестакова МВ. Роль механизмов «метаболической памяти» в развитии и прогрессировании сосудистых осложнений сахарного диабета. Сахарный диабет. 2017;20(2):126–134. https://doi.org/10.14341/7674.Chernikov AA, Severina AS, Shamhalova MSh, Shestakova MV. The role of «metabolic memory» mechanisms in the development and progression of vascular complications of diabetes mellitus. Diabetes Mellitus. 2017;20(2):126–134. (In Russ.) https://doi.org/10.14341/7674.Nathan DM, McGee P, Steffes MW, Lachin JM. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014;63(1):282–290. https://doi.org/10.2337/db13-0782.Nathan DM, McGee P, Steffes MW, Lachin JM. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014;63(1):282–290. https://doi.org/10.2337/db13-0782.Xue C, Chen K, Gao Z, Bao T, Dong L, Zhao L et al. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell Commun Signal. 2023;21(1):298. https://doi.org/10.1186/s12964-022-01016-w.Xue C, Chen K, Gao Z, Bao T, Dong L, Zhao L et al. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell Commun Signal. 2023;21(1):298. https://doi.org/10.1186/s12964-022-01016-w.Marcovecchio ML. Complications of Acute and Chronic Hyperglycemia. US Endocrinology. 2017;13(1):17–21. https://doi.org/10.17925/USE.2017.13.01.17Marcovecchio ML. Complications of Acute and Chronic Hyperglycemia. US Endocrinology. 2017;13(1):17–21. https://doi.org/10.17925/USE.2017.13.01.17Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl.):S35–42. https://doi.org/10.1016j.jacc.2008.09.055.Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009;53(5 Suppl.):S35–42. https://doi.org/10.1016j.jacc.2008.09.055.Yamagishi S, Nakamura N, Suematsu M, Kaseda K, Matsui T. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes. Mol Med. 2015;21(Suppl. 1):S32–40. https://doi.org/10.2119/molmed.2015.00067.Yamagishi S, Nakamura N, Suematsu M, Kaseda K, Matsui T. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes. Mol Med. 2015;21(Suppl. 1):S32–40. https://doi.org/10.2119/molmed.2015.00067.Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–188. https://doi.org/10.1152/physrev.00045.2011.Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–188. https://doi.org/10.1152/physrev.00045.2011.Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886–899. https://doi.org/10.1007/s00125-015-3525-8.Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886–899. https://doi.org/10.1007/s00125-015-3525-8.Pirola L. The DCCT/EDIC study: epigenetic clues after three decades. Diabetes. 2014;63(5):1460–1462. https://doi.org/10.2337/db14-0238.Pirola L. The DCCT/EDIC study: epigenetic clues after three decades. Diabetes. 2014;63(5):1460–1462. https://doi.org/10.2337/db14-0238.Liang S, Yin H, Wei C, Xie L, He H, Liu X. Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis. J Diabetes Metab Disord. 2017;16:45. https://doi.org/10.1186/s40200-017-0323-5.Liang S, Yin H, Wei C, Xie L, He H, Liu X. Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis. J Diabetes Metab Disord. 2017;16:45. https://doi.org/10.1186/s40200-017-0323-5.Wei F, Sun X, Zhao Y, Zhang H, Diao Y, Liu Z. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus. BMC Nephrol. 2016;17(1):67. https://doi.org/10.1186/s12882-016-0300-0.Wei F, Sun X, Zhao Y, Zhang H, Diao Y, Liu Z. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus. BMC Nephrol. 2016;17(1):67. https://doi.org/10.1186/s12882-016-0300-0.Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33(10):2169–2174. https://doi.org/10.2337/dc10-0389.Rizzo MR, Marfella R, Barbieri M, Boccardi V, Vestini F, Lettieri B et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33(10):2169–2174. https://doi.org/10.2337/dc10-0389.Zinman B, Marso SP, Poulter NR, Emerson SS, Pieber TR, Pratley RE et al. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018;61(1):48–57. https://doi.org/10.1007/s00125-017-4423-z.Zinman B, Marso SP, Poulter NR, Emerson SS, Pieber TR, Pratley RE et al. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia. 2018;61(1):48–57. https://doi.org/10.1007/s00125-017-4423-z.Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. https://doi.org/10.1136/bmj.321.7258.405.Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–412. https://doi.org/10.1136/bmj.321.7258.405.Ambrosi P, Daumas A, Villani P, Giorgi R. Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo. Cardiology. 2020;145(6):370–374. https://doi.org/10.1159/000506004.Ambrosi P, Daumas A, Villani P, Giorgi R. Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo. Cardiology. 2020;145(6):370–374. https://doi.org/10.1159/000506004.Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Res Clin Pract. 2018;137:137–148. https://doi.org/10.1016/j.diabres.2017.12.004.Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis. Diabetes Res Clin Pract. 2018;137:137–148. https://doi.org/10.1016/j.diabres.2017.12.004.Дедов ИИ, Шестакова МВ, Майоров АЮ (ред.). Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 11-й выпуск. М.; 2023. Режим доступа: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/2023_alg_sum.pdf.Дедов ИИ, Шестакова МВ, Майоров АЮ (ред.). Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 11-й выпуск. М.; 2023. Режим доступа: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/2023_alg_sum.pdf.Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99(6):926–943. https://doi.org/10.1016/j.pec.2015.11.003.Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99(6):926–943. https://doi.org/10.1016/j.pec.2015.11.003.Selvin E. Hemoglobin A1c-Using Epidemiology to Guide Medical Practice: Kelly West Award Lecture 2020. Diabetes Care. 2021;44(10):2197–2204. https://doi.org/10.2337/dci21-0035.Selvin E. Hemoglobin A1c-Using Epidemiology to Guide Medical Practice: Kelly West Award Lecture 2020. Diabetes Care. 2021;44(10):2197–2204. https://doi.org/10.2337/dci21-0035.Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes. 2009;1(1):9–17. https://doi.org/10.1111/j.1753-0407.2009.00009.x.Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes. 2009;1(1):9–17. https://doi.org/10.1111/j.1753-0407.2009.00009.x.McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev. 2007;23(6):423–440. https://doi.org/10.1002/dmrr.749.McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence? Diabetes Metab Res Rev. 2007;23(6):423–440. https://doi.org/10.1002/dmrr.749.Майоров АЮ, Мельникова ОГ, Филиппов ЮИ. Вопросы самоконтроля гликемии в практике лечения сахарного диабета. Справочник поликлинического врача. 2012;(12):32–36. Режим доступа: https://www.elibrary.ru/tanxdb.Mayorov AYu, Melnikova OG, Filippov YuI. Issues of self-monitoring of glycemia in the diabetes treatment practice. Spravochnik Poliklinicheskogo Vracha. 2012;(12):32–36. (In Russ.) Available at: https://www.elibrary.ru/tanxdb.Schnell O, Hanefeld M, Monnier L. Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials. J Diabetes Sci Technol. 2014;8(3):609–614. https://doi.org/10.1177/1932296814528134.Schnell O, Hanefeld M, Monnier L. Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials. J Diabetes Sci Technol. 2014;8(3):609–614. https://doi.org/10.1177/1932296814528134.Benjamin EM. Self-Monitoring of Blood Glucose: The Basics. Clin Diabetes. 2002;20(1):45–47. https://doi.org/10.2337/diaclin.20.1.45.Benjamin EM. Self-Monitoring of Blood Glucose: The Basics. Clin Diabetes. 2002;20(1):45–47. https://doi.org/10.2337/diaclin.20.1.45.ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl. 1):S111–S127. https://doi.org/10.2337/dc23-S007.ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl. 1):S111–S127. https://doi.org/10.2337/dc23-S007.Rao PV, Makkar BM, Kumar A, Das AK, Singh AK, Mithal A et al. RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India. Int J Diabetes Dev Ctries. 2018;38:260–279. https://doi.org/10.1007/s13410-018-0677-3.Rao PV, Makkar BM, Kumar A, Das AK, Singh AK, Mithal A et al. RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India. Int J Diabetes Dev Ctries. 2018;38:260–279. https://doi.org/10.1007/s13410-018-0677-3.Clar C, Barnard K, Cummins E, Royle P, Waugh N. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14(12):1–140. https://doi.org/10.3310/hta14120.Clar C, Barnard K, Cummins E, Royle P, Waugh N. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14(12):1–140. https://doi.org/10.3310/hta14120.Durán A, Martín P, Runkle I, Pérez N, Abad R, Fernández M et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinicbased interventional study with parallel groups. J Diabetes. 2010;2(3):203–211. https://doi.org/10.1111/j.1753-0407.2010.00081.x.Durán A, Martín P, Runkle I, Pérez N, Abad R, Fernández M et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinicbased interventional study with parallel groups. J Diabetes. 2010;2(3):203–211. https://doi.org/10.1111/j.1753-0407.2010.00081.x.Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262–267. https://doi.org/10.2337/dc10-1732.Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262–267. https://doi.org/10.2337/dc10-1732.Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes Technol Ther. 2009;11(12):775–784. https://doi.org/10.1089/dia.2009.0091.Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes Technol Ther. 2009;11(12):775–784. https://doi.org/10.1089/dia.2009.0091.Sia HK, Kor CT, Tu ST, Liao PY, Wang JY. Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study. Sci Rep. 2021;11(1):1176. https://doi.org/10.1038/s41598-021-81024-x.Sia HK, Kor CT, Tu ST, Liao PY, Wang JY. Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients: a retrospective cohort study. Sci Rep. 2021;11(1):1176. https://doi.org/10.1038/s41598-021-81024-x.Hou YY, Li W, Qiu JB, Wang XH. Efficacy of blood glucose self-monitoring on glycemic control in patients with non-insulin-treated type 2 diabetes: a meta-analysis. Int J Nurs Sci. 2014;1(2):191–195. https://doi.org/10.1016/j.ijnss.2014.05.003.Hou YY, Li W, Qiu JB, Wang XH. Efficacy of blood glucose self-monitoring on glycemic control in patients with non-insulin-treated type 2 diabetes: a meta-analysis. Int J Nurs Sci. 2014;1(2):191–195. https://doi.org/10.1016/j.ijnss.2014.05.003.Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–1395. https://doi.org/10.2337/dc12-2480.Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36(5):1384–1395. https://doi.org/10.2337/dc12-2480.Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res. 2013;13(1):123–130. https://doi.org/10.1586/erp.12.80.Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res. 2013;13(1):123–130. https://doi.org/10.1586/erp.12.80.Ahmad I, Zelnick LR, Batacchi Z, Robinson N, Dighe A, Manski-Nankervis JE et al. Hypoglycemia in People with Type 2 Diabetes and CKD. Clin J Am Soc Nephrol. 2019;14(6):844–853. https://doi.org/10.2215/CJN.11650918.Ahmad I, Zelnick LR, Batacchi Z, Robinson N, Dighe A, Manski-Nankervis JE et al. Hypoglycemia in People with Type 2 Diabetes and CKD. Clin J Am Soc Nephrol. 2019;14(6):844–853. https://doi.org/10.2215/CJN.11650918.Qi Y, Feng W. Cause analysis and nursing countermeasures of self-monitoring of blood glucose in diabetic patients. Electronic J Pract Clin Nurs. 2017;16:44–45. https://doi.org/10.3969/j.issn.2096-2479.2017.16.034.Qi Y, Feng W. Cause analysis and nursing countermeasures of self-monitoring of blood glucose in diabetic patients. Electronic J Pract Clin Nurs. 2017;16:44–45. https://doi.org/10.3969/j.issn.2096-2479.2017.16.034.Моргунов ЛЮ. Гипогликемия и возможности пероральной терапии сахарного диабета типа 2 при хронической болезни почек. Эндокринология: новости, мнения, обучение. 2018;7(4):23–31. https://doi.org/10.24411/2304-9529-2018-14003.Morgunov LYu. Hypoglycemia and possibilities of oral therapy of type 2 diabetes in patients with chronic kidney disease. Endocrinology: News, Opinions, Training. 2018;7(4):23–31. (In Russ.) https://doi.org/10.24411/2304-9529-2018-14003Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006;49(8):1711–1721. https://doi.org/10.1007/s00125-006-0316-2.Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006;49(8):1711–1721. https://doi.org/10.1007/s00125-006-0316-2.Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83–93. Available at: https://pubmed.ncbi.nlm.nih.gov/22872934.Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83–93. Available at: https://pubmed.ncbi.nlm.nih.gov/22872934.Evans JM, Mackison D, Emslie-Smith A, Lawton J. Self-monitoring of blood glucose in Type 2 diabetes: cross-sectional analyses in 1993, 1999 and 2009. Diabet Med. 2012;29(6):792–795. https://doi.org/10.1111/j.1464-5491.2011.03567.x.Evans JM, Mackison D, Emslie-Smith A, Lawton J. Self-monitoring of blood glucose in Type 2 diabetes: cross-sectional analyses in 1993, 1999 and 2009. Diabet Med. 2012;29(6):792–795. https://doi.org/10.1111/j.1464-5491.2011.03567.x.Freckmann G, Jendrike N, Baumstark A, Pleus S, Liebing C, Haug C. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors. Diabetes Ther. 2018;9(2):683–697. https://doi.org/10.1007/s13300-018-0392-6.Freckmann G, Jendrike N, Baumstark A, Pleus S, Liebing C, Haug C. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors. Diabetes Ther. 2018;9(2):683–697. https://doi.org/10.1007/s13300-018-0392-6.Pleus S, Freckmann G, Schauer S, Heinemann L, Ziegler R, Ji L et al. SelfMonitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus. Diabetes Ther. 2022;13(5):829–846. https://doi.org/10.1007/s13300-022-01254-8.Pleus S, Freckmann G, Schauer S, Heinemann L, Ziegler R, Ji L et al. SelfMonitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus. Diabetes Ther. 2022;13(5):829–846. https://doi.org/10.1007/s13300-022-01254-8.Jimenez G, Lum E, Huang Z, Theng YL. Reminders for medication adherence in Type 2 diabetes management apps. J Pharm Pract Res. 2020;50(1):78–81. https://doi.org/10.1002/jppr.1595.Jimenez G, Lum E, Huang Z, Theng YL. Reminders for medication adherence in Type 2 diabetes management apps. J Pharm Pract Res. 2020;50(1):78–81. https://doi.org/10.1002/jppr.1595.Parkin CG, Davidson JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol. 2009;3(3):500–508. https://doi.org/10.1177/193229680900300314.Parkin CG, Davidson JA. Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes. J Diabetes Sci Technol. 2009;3(3):500–508. https://doi.org/10.1177/193229680900300314.

The authors declare that there are no conflicts of interest present.